chr12-18694959-A-C

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS1_Supporting

The NM_033123.4(PLCZ1):​c.1412T>G​(p.Phe471Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000255 in 1,605,700 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

PLCZ1
NM_033123.4 missense

Scores

5
12
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.67

Publications

1 publications found
Variant links:
Genes affected
PLCZ1 (HGNC:19218): (phospholipase C zeta 1) The protein encoded by this gene is a member of the phosphoinositide-specific phospholipase C family. Members in this family, classified into six isotypes that are tissue- and organ-specific, hydrolyze phosphatidylinositol 4,5-bisphosphate just before the phosphate group to yield diacylglycerol and inositol 1,4,5-trisphosphate. This protein localizes to the acrosome in spermatozoa and elicits Ca(2+) oscillations and egg activation during fertilization that leads to early embryonic development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
PIK3C2G (HGNC:8973): (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma) The protein encoded by this gene belongs to the phosphoinositide 3-kinase (PI3K) family. PI3-kinases play roles in signaling pathways involved in cell proliferation, oncogenic transformation, cell survival, cell migration, and intracellular protein trafficking. This protein contains a lipid kinase catalytic domain as well as a C-terminal C2 domain, a characteristic of class II PI3-kinases. C2 domains act as calcium-dependent phospholipid binding motifs that mediate translocation of proteins to membranes, and may also mediate protein-protein interactions. This gene may play a role in several diseases, including type II diabetes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.0000268 (39/1453448) while in subpopulation SAS AF = 0.000419 (36/85904). AF 95% confidence interval is 0.000311. There are 0 homozygotes in GnomAdExome4. There are 27 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLCZ1NM_033123.4 linkc.1412T>G p.Phe471Cys missense_variant Exon 12 of 15 ENST00000266505.12 NP_149114.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLCZ1ENST00000266505.12 linkc.1412T>G p.Phe471Cys missense_variant Exon 12 of 15 1 NM_033123.4 ENSP00000266505.7 Q86YW0-1
PLCZ1ENST00000648272.1 linkc.1535T>G p.Phe512Cys missense_variant Exon 11 of 14 ENSP00000497636.1 A0A3B3ISW9
PLCZ1ENST00000539875.5 linkc.833T>G p.Phe278Cys missense_variant Exon 8 of 11 1 ENSP00000445026.1 Q86YW0-2
PLCZ1ENST00000318197.10 linkn.*1277T>G non_coding_transcript_exon_variant Exon 12 of 15 1 ENSP00000326397.6 F5H474
PLCZ1ENST00000318197.10 linkn.*1277T>G 3_prime_UTR_variant Exon 12 of 15 1 ENSP00000326397.6 F5H474

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152134
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000519
AC:
13
AN:
250354
AF XY:
0.0000739
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000268
AC:
39
AN:
1453448
Hom.:
0
Cov.:
30
AF XY:
0.0000373
AC XY:
27
AN XY:
723510
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33226
American (AMR)
AF:
0.00
AC:
0
AN:
44608
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26040
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39558
South Asian (SAS)
AF:
0.000419
AC:
36
AN:
85904
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53346
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5646
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1105042
Other (OTH)
AF:
0.0000499
AC:
3
AN:
60078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152252
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41566
American (AMR)
AF:
0.00
AC:
0
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68014
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
ExAC
AF:
0.0000741
AC:
9
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 25, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1412T>G (p.F471C) alteration is located in exon 12 (coding exon 11) of the PLCZ1 gene. This alteration results from a T to G substitution at nucleotide position 1412, causing the phenylalanine (F) at amino acid position 471 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.49
BayesDel_addAF
Uncertain
0.067
T
BayesDel_noAF
Pathogenic
0.19
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.54
.;.;D;.;.
Eigen
Uncertain
0.67
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.75
T;T;T;T;T
M_CAP
Uncertain
0.23
D
MetaRNN
Uncertain
0.59
D;D;D;D;D
MetaSVM
Uncertain
0.31
D
MutationAssessor
Pathogenic
4.3
.;.;H;.;.
PhyloP100
5.7
PrimateAI
Uncertain
0.63
T
PROVEAN
Pathogenic
-7.8
.;D;D;D;D
REVEL
Uncertain
0.50
Sift
Uncertain
0.0010
.;D;D;D;D
Sift4G
Pathogenic
0.0
.;D;D;D;.
Polyphen
1.0
.;D;D;.;.
Vest4
0.67, 0.75, 0.68
MutPred
0.52
.;.;Gain of catalytic residue at K468 (P = 0.0554);.;.;
MVP
0.88
MPC
0.15
ClinPred
0.99
D
GERP RS
5.1
PromoterAI
-0.00080
Neutral
Varity_R
0.81
gMVP
0.68
Mutation Taster
=45/55
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs563553688; hg19: chr12-18847893; API